[
    [
        {
            "time": "2018-03-15",
            "original_text": "Abbott Starts GUIDE-HF Clinical Trial for CardioMEMS Device",
            "features": {
                "keywords": [
                    "Abbott",
                    "GUIDE-HF",
                    "Clinical Trial",
                    "CardioMEMS"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "medical devices"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Abbott Starts GUIDE-HF Clinical Trial for CardioMEMS Device",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-02-09",
            "original_text": "How Eli Lilly’s Cardiovascular Products Performed in 4Q17",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Cardiovascular Products",
                    "4Q17"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "How Eli Lilly’s Cardiovascular Products Performed in 4Q17",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "Analysts’ Recommendations for Bristol-Myers Squibb in March 2018",
            "features": {
                "keywords": [
                    "Analysts’ Recommendations",
                    "Bristol-Myers Squibb",
                    "March 2018"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Analysts’ Recommendations for Bristol-Myers Squibb in March 2018",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 3,
                "Headline_Structure": 8,
                "Source_Recency": 2
            }
        }
    ]
]